If you made any changes in Pure these will be visible here soon.

Personal profile


  • 2013.02- Instructor, Department of Internal Medicine, School of Medicine, Taipei Medical University
  • 2012- Chief of hemato-oncology ward of Shuang-Ho Hospital
  • 2012- Chief of safety of chemotherapeutic agent sub-team of Cancer committee of Shuang Ho Hospital
  • 2011- Lecturer, school of medicine, Taipei Medical University
  • 2010-2011 Lecturer, National Yang-Ming University, school of medicine
  • 2010/11/1 Visiting Staff of Shuan-ho Hospital, Department of internal medicine, Division of Hematology and Oncology
  • 2010/10-2010/11 Visiting Staff of Taipei Veterans General Hospital, Department of internal medicine, Division of Hematology and Oncology
  • 2007-2010 Chief resident of Taipei Veterans General Hospital, Department of internal medicine, Division of Hematology and Oncology
  • 2004-2007 Resident doctor of Taipei Veterans General Hospital
  • 2002 Official Committee of August Meeting 2002 of International Federations of Medical Students association
  • 2002 Visiting student to Tromsoe University, Tromsoe, Norway


  • 1997-2004 National Yang-Ming University School of Medicine


  • 2009 Hsieh YY, Liu CY, Lin HN, Liu JH, Gau JP, Hsiao LT, Yu YB, Chiou TJ, Chen PM, Tzeng CH. Hematopoietic Stem Cell Transplantation (HSCT) for Cytogenetically Normal AML Patients at First Complete Remission-experience from Taipei Veterans General Hospital. The 14th APBMT, outstanding poster award

Research Interests

  • Clinical trial
  • clinical data mining of Gastrointestinal tract cancer
  • drug resistance of chemotherapeutic drug in gastrointestinal tract cancer

Fingerprint Dive into the research topics where Yao-Yu Hsieh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
oxaliplatin Medicine & Life Sciences
decitabine Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Azacitidine Medicine & Life Sciences
Bone Neoplasms Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Polypharmacology Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 148 Citations
  • 6 h-Index
  • 19 Article
  • 2 Comment/debate

HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells

Chen, S. H., Chow, J. M., Hsieh, Y. Y., Lin, C. Y., Hsu, K. W., Hsieh, W. S., Chi, W. M., Shabangu, B. M. & Lee, C. H., May 8 2019, In : International Journal of Molecular Sciences. 20, 9

Research output: Contribution to journalArticle

Open Access
Histone Deacetylase Inhibitors
K562 Cells
Cell death
Pituitary Neoplasms
Renal Cell Carcinoma
Computer Simulation
2 Citations (Scopus)

A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer

Chen, T. W-W., Yeh, D-C., Chao, T-Y., Lin, C-H., Chow, L. W-C., Chang, D-Y., Hsieh, Y-Y., Huang, S-M., Cheng, A-L. & Lu, Y-S., Mar 1 2018, In : Japanese Journal of Clinical Oncology. 48, 3, p. 242-247 6 p.

Research output: Contribution to journalArticle

Breast Neoplasms

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J. & Kelly, K., Aug 17 2018, In : Oncotarget. 9, 64, p. 32403 1 p.

Research output: Contribution to journalComment/debate

Bone Neoplasms
Protein-Tyrosine Kinases
Prostatic Neoplasms
Neoplasm Metastasis
1 Citation (Scopus)

Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining

Liu, T. P., Hsieh, Y. Y., Chou, C. J. & Yang, P. M., Nov 1 2018, In : Royal Society Open Science. 5, 11, 181321.

Research output: Contribution to journalArticle

Drug Repositioning
Pharmaceutical Preparations
Topoisomerase Inhibitors